EUVIMED · CrossrefJournal
Integrative Biomedical Research
ISSN 3068-6326 · Eman Research Publishing LLC
Latest articles
Comprehensive Review of Foundation Toxicity Models Integrating In Vivo, In Vitro, and Chemical Knowledge for Unified Risk Prediction
Dietary Bioactive Compounds in Cancer and Cardiovascular Health: A Systematic Review of Methylxanthines, Polyphenols, and Flavonoids
Serum Uric Acid Reduction Following Use of Canssu5®, a Standardized Orthosiphon stamineus Extract, in Adults with Hyperuricemia: A Retrospective Case Study
Therapeutic Angiogenesis: From Single-Factor Failures to Precision Vascular Regeneration
Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation
Organoid-on-Chip Platforms as Predictive Models of Human Disease: Promise and Pitfalls
Mitochondrial Transfer Between Cells: Physiological Roles and Therapeutic Potential
Mapping the Invisible Architecture of Disease: Spatial Multi-Omics Technologies, Computational Integration, and the Path Toward Clinical Translation
The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis
Epigenetic Clocks and Biological Ageing: From Biomarker to Intervention Target
Extracellular Vesicles as Diagnostic and Therapeutic Tools: Closing the Translational Gap
Single-Cell and Spatial Transcriptomics in Precision Diagnostics: A Roadmap for Clinical Adoption
Tissue-Resident Memory T Cells in Health and Disease: Emerging Regulators of Immunity
An Integrated AI-Driven Framework for Maternal Resource Intelligence Shortages Across U.S. Hospital
Predicting Parkinson’s Disease Progression Using Statistical And Neural Mixed Effects Models: Comparative Study On Longitudinal Biomarkers
AI-driven Innovations in Cancer Research and Personalized Healthcare
Integrative Molecular and Microbial Mechanisms Linking Liver Fibrosis, Cancer Biology, and Host-Microbe Interactions
Why Artificial Intelligence Models for Antimicrobial Resistance Still Fail at the Bedside: A Review of Validation, Explainability, and Equity Gaps
From Days to Hours: Artificial Intelligence in Antimicrobial Resistance Diagnostics and Drug Discovery, and Why No Tool Has Yet Reached the Clinic
Reproducibility, Algorithmic Bias, and Clinical Readiness in Medical Imaging AI: A Lifecycle-Based Synthesis and Multi-Institutional Validation Protocol
Long COVID as a Network Disorder: Mechanisms, Biomarkers, and the Path Toward Mechanism-Anchored Clinical Stratification
Multimorbidity in Ageing Populations: Redefining Clinical Guidelines for Combined Disease Management
Integrating Genomics, Transcriptomics, and Organoid-Based Drug Testing for Precision Cancer Care
Emerging CRISPR-Cas, Antibody, and Nanomedicine Strategies Against Antimicrobial Resistance in Critical Care
Digital Biomarkers and Wearable Bioelectronics Across Neurological, Cardiopulmonary, and Mental Health Conditions: Clinical Evidence and Barriers to Adoption
Obesity Pharmacotherapy in the GLP-1 Era: Efficacy, Equity, and the Long-Term Unknowns of Incretin-Based Care
Modifiable Triggers and Autoimmune Disease Flares: A Mechanistic and Clinical Synthesis of Molecular Mimicry, Barrier Disruption, and Neuroendocrine-Microbial Crosstalk
Artificial Intelligence in Precision Cardiovascular Medicine: Risk Prediction, Digital Twins, and Explainability
Sex and Gender Differences in Drug Response as an Underused Variable in Precision Medicine
Managing Multidrug-Resistant Infections in Immunocompromised Patients: Bridging Current Evidence and Unmet Clinical Needs
EUVIMED